As products enter clinic...scientists shown the door.

Companies are left with fewer resources to do early stage research as their focus shifts when their products enter clinical trials

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Author information

Related links

Related links

Related external links

Exelixis

OSI Pharmaceuticals

Onyx

Millennium

Rights and permissions

Reprints and Permissions

About this article

Further reading